These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32407811)
1. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users. Lazorwitz A; Dindinger E; Harrison M; Aquilante CL; Sheeder J; Teal S Contraception; 2020 Sep; 102(3):180-185. PubMed ID: 32407811 [TBL] [Abstract][Full Text] [Related]
2. Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users. Lazorwitz A; Aquilante CL; Oreschak K; Sheeder J; Guiahi M; Teal S Obstet Gynecol; 2019 Apr; 133(4):783-794. PubMed ID: 30870275 [TBL] [Abstract][Full Text] [Related]
3. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users. Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827 [TBL] [Abstract][Full Text] [Related]
4. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception. Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294 [TBL] [Abstract][Full Text] [Related]
5. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant. Romano ME; Braun-Courville DK J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532 [TBL] [Abstract][Full Text] [Related]
6. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Ireland LD; Goyal V; Raker CA; Murray A; Allen RH Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904 [TBL] [Abstract][Full Text] [Related]
7. The association between BMI and continuity of etonogestrel (ENG)-releasing implant. Mohr-Sasson A; Dalal L; Bhalwal A Int J Gynaecol Obstet; 2024 Oct; 167(1):254-258. PubMed ID: 38712353 [TBL] [Abstract][Full Text] [Related]
8. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users. Lazorwitz A; Sheeder J; Teal S Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):323-325. PubMed ID: 33596152 [TBL] [Abstract][Full Text] [Related]
9. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217 [TBL] [Abstract][Full Text] [Related]
10. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152 [TBL] [Abstract][Full Text] [Related]
11. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration. McNicholas C; Swor E; Wan L; Peipert JF Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241 [TBL] [Abstract][Full Text] [Related]
12. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users. Diamond B; Sheeder J; Lazorwitz A Contraception; 2024 Jan; 129():110298. PubMed ID: 37802462 [TBL] [Abstract][Full Text] [Related]
13. Comparison of weight gain between levonorgestrel and etonogestrel implants after 12 months of insertion. Okunola TO; Bola-Oyebamiji SB; Sowemimo O Int J Gynaecol Obstet; 2019 Oct; 147(1):54-58. PubMed ID: 31265128 [TBL] [Abstract][Full Text] [Related]
14. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients. Lew J; Sheeder J; Lazorwitz A Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509 [TBL] [Abstract][Full Text] [Related]
15. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial. Hou MY; McNicholas C; Creinin MD Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258 [TBL] [Abstract][Full Text] [Related]
16. Amenorrhea in adolescents using the etonogestrel contraceptive implant. Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B Contraception; 2024 May; 133():110413. PubMed ID: 38401772 [TBL] [Abstract][Full Text] [Related]
17. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants. López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853 [TBL] [Abstract][Full Text] [Related]
18. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial. Chen MJ; Hsia JK; Creinin MD Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473 [TBL] [Abstract][Full Text] [Related]
19. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users. Lazorwitz A; Davis A; Swartz M; Guiahi M Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788 [TBL] [Abstract][Full Text] [Related]
20. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users. Lazorwitz A; Seale R; Davis A; Guiahi M Contraception; 2020 Jul; 102(1):58-60. PubMed ID: 32325076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]